X
ALT icon

Xponance’s Altimmune ALT Stock Holding History

Xponance’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.2K Buy
+10,783
New +$45.8K ﹤0.01% 1653

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Xponance's ALT Position: Q1 2026 in Review

Xponance opened a new position in Altimmune (ALT) in Q1 2026: 10,783 shares worth $33.2K. The stake represents ﹤0.01% of the portfolio and ranks #1653 among its holdings.

173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Xponance held 10,783 shares of Altimmune worth $33.2K as of Q1 2026.
  • Altimmune was a new Xponance position in Q1 2026.
  • Altimmune made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1653 holding.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.